The complete guide to positional therapy for sleep apnea

Gravity and upper-airway anatomy can make the tongue and soft tissues narrow the airway more when a susceptible person sleeps supine. Moving to a lateral position can reduce collapse for a positional phenotype but cannot correct every anatomical or non-anatomical cause of OSA.^{See reference 1,See reference 2}

Positional OSA is commonly defined by a supine AHI at least twice the non-supine AHI, but definitions and minimum time in each position vary. The non-supine residual AHI and oxygen burden determine whether avoidance alone is likely to be adequate.^{See reference 3,See reference 4}

Efficacy is the reduction while the device is used; effectiveness also includes comfort, nightly adherence and durability. A less powerful therapy used consistently can help, but only objective retesting shows whether residual disease is acceptable.^{See reference 5,See reference 6}

Cochrane evidence suggests positional therapy reduces AHI and sleepiness versus inactive control in positional OSA, while CPAP reduces AHI more and positional therapy may be worn longer.^{See reference 1,See reference 3}

Modern vibrotactile devices reduce supine sleep and AHI in short-term trials and meta-analyses; a 2026 sham-controlled trial found a modest three-month AHI reduction and improved sleep quality but not daytime sleepiness.^{See reference 2,See reference 4}

It can be a useful adjunct to PAP or oral-appliance therapy when residual events are position-dependent, but combination decisions need objective reassessment.^{See reference 5,See reference 6}

Trials use different positional definitions, devices and OSA severities, and many are short. Results cannot be generalized to non-positional, central or severe hypoxemic disease.^{See reference 3,See reference 7}

A device can successfully prevent back sleeping while residual lateral OSA remains clinically important. Position adherence is not the same as treatment success.^{See reference 5,See reference 8}

Older tennis-ball or bulky methods may be inexpensive but cause discomfort and poor long-term use; newer vibrotactile devices cost more and still do not guarantee adherence or control.^{See reference 9,See reference 10}

Ask for the sleep-study table by position and write down the clinician-agreed target: residual AHI, oxygen, symptoms and minimum use.^{See reference 1,See reference 2}

Choose a method you can remove quickly and that does not restrict breathing or unsafe movement; adjust one fit variable at a time.^{See reference 3,See reference 4}

Schedule verification before starting so improved snoring or an app's position graph does not become a substitute for a treatment study.^{See reference 5,See reference 6}

It is most appropriate for adults with objectively confirmed positional OSA and a low enough non-supine burden that a sleep clinician considers avoidance meaningful.^{See reference 2,See reference 4}

It may help as an adjunct when PAP or an oral appliance leaves position-dependent events, or as an alternative in selected mild-to-moderate cases after shared decision-making.^{See reference 5,See reference 7}

It is unlikely to be sufficient for non-positional OSA, substantial residual lateral disease, central apnea or major oxygen impairment without another effective treatment.^{See reference 8,See reference 10}